Geviti

Geviti is a Utah-based longevity and precision health company that launched with the goal of making biomarker-driven, physician-supervised health optimization accessible at a price point that does not require the income of a Silicon Valley executive. The company was founded on the observation that the longevity medicine market — with its $15,000–$85,000 per year executive health programs and $300+/month telehealth memberships — serves a narrow demographic, while the vast majority of health-motivated Americans have no access to comprehensive biomarker monitoring or the prescription therapies that can meaningfully improve how they age. Geviti's answer is a tiered membership model starting at $54/month, built around what the company calls the Longeviti Panel — a twice-yearly blood draw analyzing more than 90 biomarkers spanning hormones, metabolic health, cardiovascular risk, inflammation, nutrient status, and biological aging markers. This is significantly more comprehensive than the panels offered at most primary care visits and comparable in depth to diagnostics at much higher-priced platforms. The twice-yearly frequency — rather than the quarterly retesting of premium competitors — is part of what keeps the cost accessible. The most strategically interesting aspect of Geviti's model is its wholesale prescription pricing structure. Rather than marking up compounded hormones, peptides, and GLP-1 medications by the industry-standard 200–300%, Geviti offers members access to prescriptions at manufacturer-level pricing. For patients who are on multiple protocols — testosterone, a GH peptide, and a GLP-1 medication, for example — this can represent hundreds of dollars per month in savings compared to other cash-pay telehealth platforms, even after accounting for the membership fee. It inverts the typical telehealth economics where the consultation is cheap but the medications are the hidden cost. In December 2025, Geviti announced expansion to 47 states following its $8.5 million funding round, adding a new membership tier and significantly scaling its clinical operations. The company is actively working toward all-50-state coverage. The Geviti app serves as the central hub for members to view their biomarker trends, receive supplement and protocol recommendations, and communicate with Longevity Specialists. The platform also generates personalized supplement stacks — branded as the Longeviti Blend — formulated based on each member's specific biomarker deficiencies rather than generic wellness formulas. For patients who are ready to treat their health as a data problem — collecting rigorous information twice a year, acting on it clinically, and tracking improvement over time — Geviti offers a compelling combination of clinical depth and price accessibility that few competitors match. The company was founded on the observation that the longevity medicine market — with its $15,000–$85,000 per year executive health programs and $300+/month telehealth memberships — serves a narrow demographic, while the vast majority of health-motivated Americans have no access to comprehensive biomarker monitoring or the prescription therapies that can meaningfully improve how they age. Geviti's answer is a tiered membership model starting at $54/month, built around what the company calls the Longeviti Panel — a twice-yearly blood draw analyzing more than 90 biomarkers spanning hormones, metabolic health, cardiovascular risk, inflammation, nutrient status, and biological aging markers. This is significantly more comprehensive than the panels offered at most primary care visits and comparable in depth to diagnostics at much higher-priced platforms. The twice-yearly frequency — rather than the quarterly retesting of premium competitors — is part of what keeps the cost accessible. The most strategically interesting aspect of Geviti's model is its wholesale prescription pricing structure. Rather than marking up compounded hormones, peptides, and GLP-1 medications by the industry-standard 200–300%, Geviti offers members access to prescriptions at manufacturer-level pricing. For patients who are on multiple protocols — testosterone, a GH peptide, and a GLP-1 medication, for example — this can represent hundreds of dollars per month in savings compared to other cash-pay telehealth platforms, even after accounting for the membership fee. It inverts the typical telehealth economics where the consultation is cheap but the medications are the hidden cost. In December 2025, Geviti announced expansion to 47 states following its $8.5 million funding round, adding a new membership tier and significantly scaling its clinical operations. The company is actively working toward all-50-state coverage. The Geviti app serves as the central hub for members to view their biomarker trends, receive supplement and protocol recommendations, and communicate with Longevity Specialists. The platform also generates personalized supplement stacks — branded as the Longeviti Blend — formulated based on each member's specific biomarker deficiencies rather than generic wellness formulas. For patients who are ready to treat their health as a data problem — collecting rigorous information twice a year, acting on it clinically, and tracking improvement over time — Geviti offers a compelling combination of clinical depth and price accessibility that few competitors match.

Who it suits

Health-conscious men and women who want rigorous twice-yearly biomarker testing and access to longevity-focused prescriptions (hormones, peptides, GLP-1s) at wholesale pricing, without paying the premium membership fees of top-tier platforms. Geviti is particularly well-suited for patients who are already somewhat educated about their health metrics and want more frequent data and clinical support than their primary care doctor provides, but who don't need a concierge physician relationship. It is available in 47 states, making it one of the broadest-reach longevity platforms in the US. It is not ideal for patients who need same-day or urgent care, those who want frequent hands-on physician time, or individuals in the three states currently not served.

How Geviti compares

Geviti is most closely comparable to Lifeforce and Function Health as a biomarker-driven longevity platform, but it carves out a distinct position through its pricing structure and prescription access model. Where Lifeforce charges $149/month and Opt Health's Optimization tier runs $300+/month, Geviti's tiered plans start at $54/month (Lite) and $110/month (Plus) — making it one of the most affordable entry points for 90+ biomarker testing paired with clinical access. The critical differentiator is Geviti's wholesale prescription pricing: members pay manufacturer-level costs for peptides, GLP-1 medications, hormones, and other Rx therapies rather than the 200–300% retail markups typical in the direct-pay market. This model can make Geviti significantly cheaper total-cost than competitors for members who are actually on multiple prescriptions. Function Health offers more biomarkers but no clinical prescribing; Geviti's Plus Rx tier adds clinical prescription access to the diagnostic depth.

Care offered

• Longevity & Anti-Aging

Included

• Initial Evaluation & Diagnosis
• Medication Management
• Lab Orders

Convenience

• App-Based Care

Cost

Pricing not confirmed. Check Geviti's website for current prices.

Geviti offers three membership tiers: Lite ($54/month), Plus ($110/month), and Plus Rx ($128/month). All tiers include the Longeviti Panel — testing 90+ biomarkers of longevity — twice per year. Plus and Plus Rx add access to Longevity Specialist coaching and prescription services respectively, including hormones, peptides, GLP-1s, and metabolic enhancers at wholesale pricing. A 40% discount on Geviti's personalized supplement stacks is included across all tiers. Medications are priced separately from the membership at wholesale rates.

Insurance

Self-pay accepted (insurance not confirmed)

States served by telehealth

8 states

• CA
• CO
• TX
• FL
• AZ
• WA
• NY
• GA

Telehealth providers must be licensed in the state where you are during the visit.

How to start

Visit gogeviti.com and select your membership tier; after completing an intake questionnaire, you are guided through lab scheduling. For Plus Rx members, a clinician consultation is scheduled following your lab results to review findings and initiate prescriptions.